Search

everythinglearnresearchcommunity

for

Search:↓

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

Feminizing hormone therapy increases kidney filtration rate.

Inclusive and culturally competent healthcare is crucial for transgender and non-binary individuals.

Male pattern baldness may indicate arterial stiffness in transgender men on long-term testosterone therapy.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Bilateral Orchiectomy effectively reduces the need for anti-androgen medication in most transgender females.

U.S. dermatology residents need more education and experience with LGBT patients to improve their cultural competency.

Transgender treatment includes hormones and surgery, but long-term effects are unknown and counseling is needed.

Transgender youth have more sleep disorders, but gender-affirming therapy may help reduce them.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

Inclusive and affirming healthcare is essential for improving transgender individuals' quality of life and health.

Hair transplantation is important for transgender patients to enhance their masculine or feminine appearance.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Cyproterone Acetate effectively treats androgen-related conditions and is used in prostate cancer therapy and hormone therapy for transgender women.

This special edition focuses on the unique aspects of treating skin conditions in women, including during pregnancy and in diverse populations like women of color and transgender patients.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Transmasculine individuals on testosterone therapy need tailored contraception and fertility advice due to unique risks and benefits of each contraceptive method.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Adults with gender dysphoria on hormone treatment often have skin problems like acne, which are common but not always recognized.

Hormonal therapy in adults with gender dysphoria often leads to skin issues like acne, requiring a team of skin and hormone doctors.

The conclusion is that recognizing the difference between gender identity and biological sex is crucial in dermatology to improve patient care and research accuracy.

Accurate gender and sex assessment in dermatology is essential for respectful and precise patient care.

The document summarized various dermatology studies and case reports.